arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Embecta Corp.

EMBC
$5.59 ▼ -0.01 (-0.18%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
7 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Bullish
auto_awesome

Analytical Summary

Embecta Corp. shows strong fundamentals with top-quartile Debt to Equity and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $325.9M
Dividend Yield 10.73%
Revenue Growth -3.8% ↘
Op. Margin 22.4% ↗
ROIC 22.7% ↘
FCF / Share $3.13 ↗
Trailing P/E 3.4x
Price / Book —
FCF Yield 56.0%
Debt / Equity -2.15
info Valuation on last close. End-of-day price, Sep 23, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.08B
↓ -3.8% —
Net Income Profit after all expenses
$95.40M
↑ +21.8% —
Operating Margin Operating profit as % of sales
22.4%
↑ +50.9% 78th
FCF / Share Free cash flow per share
$3.13
↑ +806.7% —
Long-Term Debt Long-term obligations
$1.40B
↓ -11.2% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Operating Margin (%)Operating Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
72
Returns
31
Financial Health ↓
81
Cash Quality ↑
85

Dividend History

Dividend / share · sourced from SEC filings
$0.60 Latest / share
+0.0% YoY
+58.7% 4-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 25 quarters